Burling Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Burling Wealth Partners's AMGN Position: Q1 2026 in Review
Burling Wealth Partners reduced its Amgen (AMGN) stake by 0.88% in Q1 2026, selling an estimated $4.63K and leaving 1,472 shares worth $518K. The position accounts for 0.08% of the portfolio, ranked #125.
Burling Wealth Partners first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Burling Wealth Partners held 1,472 shares of Amgen worth $518K as of Q1 2026.
- Burling Wealth Partners sold 13 Amgen shares in Q1 2026, an estimated $4.63K.
- Amgen made up 0.08% of Burling Wealth Partners's portfolio in Q1 2026, its #125 holding.
- Burling Wealth Partners first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Burling Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.